Cell Therapeutics Inc. (CTIC) Narrows Q3 Loss to 38c/Share
Cell Therapeutics Inc. (NASDAQ: CTIC) reported ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)